Janssen Pharmaceuticals Accused of Hiding Risperdal’s Breast Effects In Boys

Forbes, 30 August 2015
Author: Emily Willingham
“Risperidone is an antipsychotic with known side effects that clinicians must balance against its benefits for a subset of autistic people. Now Janssen Pharmaceuticals, Inc., a Johnson & Johnson JNJ company that markets this drug as Risperdal, has been accused of hiding evidence back in 2003 that would have alerted clinicians and regulatory authorities to the connection among risperidone, increased prolactin, and gynecomastia.”
Find article here.